Sponsored Videos

A Successful Approach to Leveraging Technology Solutions with Kyle Pratt

Putting Them Both into Action with AmplifyBio for Real Results and Real Outcomes

Whether you are considering a new facility build or a facility upgrade, IPS has expert teams using the latest technologies to bring you strategies that provide cost certainty, real-time updates, and successful construction project management.

We have proposed a comprehensive capping index parameter which is a ratio of compact anisotropic index to material anisotropic index. This study will help to design or select right tooling for successful tablet manufacturing.

Learn how the application of artificial intelligence (AI) and proactive service helps resolve potential production problems before they occur. This ensures reliable water quality, maximizes uptime, and improves overall production costs.

Logan Instruments discuses diffusion cell testing and what sets their company apart from other manufacturers.

Anthony Carpanzano, Director of R&D at JRS Pharma, discussed ongoing formulation challenges and trends.

The first segment of this five-part PPD Tech Talk series on A CMC Roadmap for Cell and Gene Therapies, Katherine Hanson, Ph.D., associate director at PPD Laboratory services, GMP Lab, discusses regulatory considerations for cell and gene therapies.

The second segment of this five-part PPD Tech Talk series Jie Ding, director, and Derek Wood, associate director, at PPD Laboratory services, GMP Lab, discuss pre-requisites such as LC-MS and extractables and leachables (E&L) implications.

In the third part of this five part series, Marc Wolman, labs manager, biopharmaceutical at PPD Laboratory services, GMP Lab, & Jurgen Hannig, senior principal scientist at PPD Laboratory services talk about new analytical tools for cell & gene therapies.

In the fourth part of this five-part series, Ryan Ellefson, director of lab informatics & data analytics, at PPD Laboratory services GMP Lab, and Benjamin Ziehr, senior group leader at PPD Laboratory services GMP Cell Lab, discuss data automation.

In the final segment of this five-part series, A CMC Roadmap to Cell and Gene Therapies, Derrick McVicker, group leader, at PPD Laboratory services, GMP Lab, discusses the transfer of bioanalytical methods to GMP Lab.

An interview with Tom Sellig the Chief Executive Officer of Adare Pharma Solutions at the CPHI Conference in Frankfurt, Germany.

This is the first segment of this three-part PPD Tech Talk series on Improving Clinical Trials with Innovative Data Solutions featuring experts Olivia Aspite and Bryan Neth of PPD®, part of Thermo Fisher Scientific.

This is the second segment of this three-part PPD Tech Talk series on Improving Clinical Trials with Innovative Data Solutions featuring experts Chris Clendening and Tim Rich.

This is the final segment of this three-part PPD Tech Talk series on Improving Clinical Trials with Innovative Data Solutions featuring experts John Maier and Renay Perry of PPD®, part of Thermo Fisher Scientific.

This video is an interview with Jon Brice, Vice President of Business Development at Asymchem at the AAPS Conference in Boston, Massachusetts.

Learn about the benefits of tailored active pharmaceutical ingredient [API] nanoparticles in this webinar with Christopher P. Worrall, Ph.D. This presentation looks at how API nanoparticles enable patient-centric therapies and benefit many dosage forms, as well as how industry collaborations drive novel drug delivery approaches.

Learn how TargTex partners with Nanoform to produce therapies for Glioblastoma patients. This process includes identifying novel targets with small molecules, utilizing Nanoform technology to increase the active pharmaceutical ingredient [API] concentration, and improving treatment stability to move the drug to clinical development.

What does Ascendia do? What sets Ascendia apart from its competitors? What is Ascendia's company culture like?